+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 120 Pages
  • Australia, New Zealand Australia, New Zealand
From
From
From
From
From
Geographic Atrophy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Geographic Atrophy Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Acute Ischemic Stroke - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Ischemic Stroke - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
From
From
Ischemic Stroke - Pipeline Insight, 2025 - Product Thumbnail Image

Ischemic Stroke - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
From
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Loading Indicator